Leukemia drug dosing study aims to protect kids
NCT ID NCT03481881
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how children with leukemia process common medicines like painkillers, diuretics, and antibiotics. Researchers will measure drug levels in the blood to better understand dosing. The goal is to make these drugs safer and more effective for kids. No new treatment is being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- standard of care drugs (e.g., furosemide, tacrolimus, fentanyl)
- What this could lead to
- If successful, this could help doctors give safer, more effective doses of these drugs to children with leukemia.
- What could go wrong
- This is an observational study, not a treatment trial. It won't directly improve health, and results may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC ALL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University
RECRUITINGDurham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone VR headset distract kids from burn pain?
- New web tool aims to help families navigate tough choices on home ventilation for children
- Could kids have upper limb surgery fully awake? new trial tests the idea
- Cartoon calm: animated film may ease Kids' surgery fears
- New study examines artery complications in child liver transplants
- Protein and exercise combo tested to fight muscle loss in sick kids